Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This research study is evaluating the ability for people with metastatic gastrointestinal cancer to participate in a physical activity program.
The physical activity program is 12-weeks in length, and includes moderate-intensity aerobic, strength, flexibility, and balance training.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 12-week physical activity program | Experimental | The physical activity program is of moderate intensity and consists of aerobic, strength, flexibility, and balance training with a target duration of 150 minutes per week.
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Physical Activity Program | Other | 12-weeks in length, and includes moderate-intensity aerobic, strength, flexibility, and balance training. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of Accrual | Recruit 20 patients within 12 months | 12 months |
| Number of participants that adhered to physical activity program | Demonstrate that at least 50% of patients adhered to at least 50% of the prescribed physical activity program. | 12 Weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of Retention | Proportion of participants who complete the study | 12 Weeks |
| Number of participants that complete assessment procedures | Physical function testing and questionnaire collection |
Not provided
Inclusion Criteria:
Start of trial:
Phase 1 (most strict) Eligibility criteria include:
Phase 2 (less restrictive) Eligibility criteria will loosen:
-- The minimum age from greater than 65, to greater than 55;
Phase 3 (least restrictive) Eligibility criteria will add:
-- The minimum age from greater than 55, to greater than 18.
Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jeffrey Meyerhardt, MD | Dana-Farber Cancer Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35722047 | Derived | Brown JC, Brighton E, Campbell N, McCleary NJ, Abrams TA, Cleary JM, Enzinger PC, Ng K, Rubinson D, Wolpin BM, Yurgelun MB, Meyerhardt JA. Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility study. BMJ Open Sport Exerc Med. 2022 May 30;8(2):e001353. doi: 10.1136/bmjsem-2022-001353. eCollection 2022. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 12 Weeks |
| Number of participants with adverse events | Falls, hospitalizations, and musculoskeletal injury | 12 Weeks |
| D005767 |
| Gastrointestinal Diseases |
| D001519 | Behavior |